Advanced Solid Tumors: Debio 0123 Treatment

We are evaluating the safety and early anti-tumor effects of Debio 0123 in adults with advanced solid tumors. This study aims to see how well this treatment works compared to existing options.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Complexo Hospitalario Universitario A Coruna
Oncologia Medica
A Coruña, Spain
Hospital Universitari Vall D Hebron
Oncologia
Barcelona, Spain
Hospital Universitario La Paz
Oncologia
Chamartín, Spain

Sponsor: Debiopharm International S.A.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.